Skip to main navigation
Contact
Careers
Home
Menu
About
Overview
Mission
Management Team
Board of Directors
Scientific Advisory Board
Sine Technology
Drug Candidates
Pipeline
Oral Selinexor (KPT-330)
Oral Verdinexor (KPT-335)
Oral KPT-350
Oral Dual Inhibitor of PAK4
and NAMPT (KPT-9274)
Investigator Sponsored Trials (IST)
Investors
Corporate Profile
Press Releases
Events & Presentations
Corporate Governance
Management Team
Board of Directors
Committee Composition
Contact the Board
Financials & Filings
SEC Filings
Annual Reports and Proxies
Quarterly Results
Key Ratios
Stock Information
Historic Stock Lookup
Investment Calculator
Dividend History
Ownership Profile
Analyst Coverage
Investor FAQs
Contact Us
Email Alerts
Investigator Sponsored Trials (IST)
Publications
Papers
Posters and Presentations
Patients & Caregivers
Patients & Caregivers Overview
Clinical Trials
Resources
Search
Contact
Careers
Karyopharm Therapeutics 2Q Conference Call
Aug 4, 2016 at 8:30 AM EDT
Listen to webcast